Kyle Clark - 03 Nov 2025 Form 3 Insider Report for BETA Technologies, Inc. (BETA)

Signature
/s/ Brian Dunkiel, as attorney-in-fact
Issuer symbol
BETA
Transactions as of
03 Nov 2025
Transactions value $
$0
Form type
3
Filing time
03 Nov 2025, 19:45:05 UTC
Next filing
12 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clark Kyle Chief Executive Officer and President; Exhibit 24.1 - Power of Attorney, Director C/O BETA TECHNOLOGIES, INC., 1150 AIRPORT DRIVE, SOUTH BURLINGTON /s/ Brian Dunkiel, as attorney-in-fact 03 Nov 2025 0002090083

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BETA Class A common stock 241K 03 Nov 2025 Direct F1
holding BETA Class A common stock 5.72M 03 Nov 2025 By The Kyle B. Clark Irrevocable Trust-2020 F2
holding BETA Class A common stock 1.62M 03 Nov 2025 By the Katie S. Clark Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BETA Employee Stock Option 03 Nov 2025 Class A common stock 72.2K $17.24 Direct F3
holding BETA Employee Stock Option 03 Nov 2025 Class A common stock 725K $17.24 Direct F4
holding BETA Employee Stock Option 03 Nov 2025 Class A common stock 798K $17.24 Direct F5
holding BETA Class B common stock 03 Nov 2025 Class A common stock 3.79M Direct F6
holding BETA Class B common stock 03 Nov 2025 Class A common stock 4.71M By The Kyle B. Clark Irrevocable Trust-2020 F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares of Class A common stock ("Class A Shares"), and all amounts of the securities reflected in this Statement, give effect to the Issuer's 6.381168-for-1 stock split effected in connection with the Issuer's initial public offering.
F2 The Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.
F3 The reported options were granted on December 1, 2023 and commenced vesting on December 15, 2023 in five installments of (i) 20% on each of the first four anniversaries of December 31, 2023, and (ii) the final 20% on June 15, 2028, and will be fully vested on June 15, 2028.
F4 The reported options were granted on December 1, 2023 and commenced vesting on December 15, 2023, in four installments of (i) 10% on the first anniversary of the vesting commencement date, (ii) 20% on the second anniversary of the vesting commencement date; (iii) 30% on the third anniversary of the vesting commencement date and (iv) 40% on the fourth anniversary of the vesting commencement date, and will be fully vested on December 15, 2027.
F5 The reported options were granted on February 18, 2025 and commenced vesting on January 1, 2025, in four installments of (i) 10% on the first anniversary of the vesting commencement date, (ii) 20% on the second anniversary of the vesting commencement date; (iii) 30% on the third anniversary of the vesting commencement date and (iv) 40% on the fourth anniversary of the vesting commencement date, and will be fully vested on January 1, 2029.
F6 The Reported Securities are convertible on a 1-for-1 basis into Class A Shares and have no expiration date.

Remarks:

Chief Executive Officer and President; Exhibit 24.1 - Power of Attorney